Compare CMG & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMG | HLN |
|---|---|---|
| Founded | 1993 | 2022 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Restaurants | Package Goods/Cosmetics |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.9B | 43.7B |
| IPO Year | 2006 | N/A |
| Metric | CMG | HLN |
|---|---|---|
| Price | $38.47 | $10.86 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 27 | 1 |
| Target Price | ★ $47.19 | N/A |
| AVG Volume (30 Days) | ★ 18.2M | 7.9M |
| Earning Date | 02-03-2026 | 02-26-2026 |
| Dividend Yield | N/A | ★ 1.68% |
| EPS Growth | 2.70 | ★ 41.64 |
| EPS | ★ 1.14 | 0.23 |
| Revenue | $11,925,601,000.00 | ★ $15,096,588,575.00 |
| Revenue This Year | $10.69 | $1.51 |
| Revenue Next Year | $11.36 | $4.67 |
| P/E Ratio | ★ $35.03 | $47.13 |
| Revenue Growth | ★ 5.41 | N/A |
| 52 Week Low | $29.75 | $8.71 |
| 52 Week High | $59.19 | $11.42 |
| Indicator | CMG | HLN |
|---|---|---|
| Relative Strength Index (RSI) | 47.25 | 71.79 |
| Support Level | $37.42 | $10.28 |
| Resistance Level | $40.25 | $10.57 |
| Average True Range (ATR) | 1.32 | 0.16 |
| MACD | -0.29 | 0.05 |
| Stochastic Oscillator | 25.63 | 94.22 |
Chipotle is a leading fast-casual, Mexican-inspired restaurant chain, generating $11.3 billion in sales across 3,644 company-operated US locations, 82 international units primarily in Canada and Europe, and three licensed stores operated with Alshaya Group in the Middle East at the end of 2024. The firm's revenue is primarily driven by food and beverage sales at its company-owned restaurants, supplemented by delivery fees generated through its first-party digital channels. Chipotle emphasizes ingredients with no artificial flavors and utilizes an efficient, assembly-line service model to serve mainly customizable burritos, bowls, salads, quesadillas, and tacos.
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.